• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study.评估年龄和聚合酶链反应检测结果与 COVID-19 死亡率的性别差异:一项伊朗多中心研究。
Expert Rev Anti Infect Ther. 2022 Apr;20(4):631-641. doi: 10.1080/14787210.2022.2000860. Epub 2021 Nov 26.
2
Thoracic imaging tests for the diagnosis of COVID-19.用于诊断新型冠状病毒肺炎的胸部影像学检查
Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3.
3
A Large Retrospective Study of Epidemiological Characteristics of COVID-19 Patients in the North of Iran: Association between SARS-CoV-2 RT-PCR Ct Values with Demographic Data.伊朗北部 COVID-19 患者的大回顾性研究:SARS-CoV-2 RT-PCR Ct 值与人口统计学数据的关联。
Int J Clin Pract. 2022 Feb 28;2022:1455708. doi: 10.1155/2022/1455708. eCollection 2022.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
The Association of Age, Sex, and RT-PCR Results with the Lymphocyte and Neutrophil Counts in SARS-CoV-2 Infection: A Cross-sectional Analysis of 1450 Iranian Patients with COVID-19.年龄、性别和 RT-PCR 结果与 SARS-CoV-2 感染中的淋巴细胞和中性粒细胞计数的关系:对 1450 例伊朗 COVID-19 患者的横断面分析。
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):129-139.
6
Predictors of negative first SARS-CoV-2 RT-PCR despite final diagnosis of COVID-19 and association with outcome.尽管最终诊断为 COVID-19,但首次 SARS-CoV-2 RT-PCR 为阴性的预测因素及其与结局的关系。
Sci Rep. 2021 Jan 27;11(1):2388. doi: 10.1038/s41598-021-82192-6.
7
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.癌症患者出现 COVID-19 症状,无论 RT-PCR 是否检测到 SARS-COV-2,死亡率均较高。
Eur J Cancer. 2020 Aug;135:251-259. doi: 10.1016/j.ejca.2020.05.028. Epub 2020 Jun 7.
8
Thoracic imaging tests for the diagnosis of COVID-19.用于诊断新型冠状病毒肺炎的胸部影像学检查
Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2.
9
COVID-19 Pandemic Experiences in Pediatric Intensive Care Unit: An Iranian Referral Hospital-Based Study.COVID-19 大流行在儿科重症监护病房的体验:一项基于伊朗转诊医院的研究。
Int J Clin Pract. 2022 Oct 25;2022:1682986. doi: 10.1155/2022/1682986. eCollection 2022.
10
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.伊朗 18 个城市一般人群和高风险职业人群中 SARS-CoV-2 抗体血清流行率:一项基于人群的横断面研究。
Lancet Infect Dis. 2021 Apr;21(4):473-481. doi: 10.1016/S1473-3099(20)30858-6. Epub 2020 Dec 15.

引用本文的文献

1
Sex and age differences in the COVID-19 mortality in East Jakarta, Indonesia: Analysis of COVID-19 surveillance system.印度尼西亚雅加达东部新冠肺炎死亡率的性别和年龄差异:新冠肺炎监测系统分析
J Public Health Afr. 2022 Dec 7;13(Suppl 2):2420. doi: 10.4081/jphia.2022.2420.
2
A follow up study of cycle threshold values of SARS-CoV-2 in Hunan Province, China.中国湖南省新型冠状病毒的循环阈值随访研究。
Infect Dis Model. 2023 Mar;8(1):203-211. doi: 10.1016/j.idm.2023.01.004. Epub 2023 Jan 20.
3
Analyzing COVID-19 mortality in Ernakulam district of Kerala: A retrospective review of death reports.分析喀拉拉邦埃纳库卢姆区的新冠肺炎死亡率:死亡报告的回顾性研究
J Family Med Prim Care. 2022 Oct;11(10):6209-6214. doi: 10.4103/jfmpc.jfmpc_648_22. Epub 2022 Oct 31.
4
Epidemiology of COVID-19 in Tehran, Iran: A Cohort Study of Clinical Profile, Risk Factors, and Outcomes.伊朗德黑兰 COVID-19 流行病学:临床特征、危险因素和结局的队列研究。
Biomed Res Int. 2022 May 10;2022:2350063. doi: 10.1155/2022/2350063. eCollection 2022.

本文引用的文献

1
Trends in COVID-19 case-fatality rates in Brazilian public hospitals: A longitudinal cohort of 398,063 hospital admissions from 1st March to 3rd October 2020.2020 年 3 月 1 日至 10 月 3 日巴西公立医院 COVID-19 病死率趋势:一项对 398,063 例住院患者的纵向队列研究。
PLoS One. 2021 Jul 16;16(7):e0254633. doi: 10.1371/journal.pone.0254633. eCollection 2021.
2
Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain.住院新冠肺炎患者的死亡率趋势:一项来自西班牙的单中心观察性队列研究。
Lancet Reg Health Eur. 2021 Apr;3:100041. doi: 10.1016/j.lanepe.2021.100041. Epub 2021 Jan 24.
3
Racial and Ethnic Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: An Analysis of 45 States and the District of Columbia.美国因 COVID-19 导致的潜在寿命损失的种族和民族差异:对 45 个州和哥伦比亚特区的分析。
Int J Environ Res Public Health. 2021 Mar 12;18(6):2921. doi: 10.3390/ijerph18062921.
4
COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis.COVID-19 住院患者病死率:系统评价和荟萃分析。
Ann Epidemiol. 2021 May;57:14-21. doi: 10.1016/j.annepidem.2021.02.012. Epub 2021 Mar 2.
5
Effect of Sex on Clinical Outcomes in Patients with Coronavirus Disease: A Population-Based Study.性别对冠状病毒病患者临床结局的影响:一项基于人群的研究。
J Clin Med. 2020 Dec 24;10(1):38. doi: 10.3390/jcm10010038.
6
False-negative results of initial RT-PCR assays for COVID-19: A systematic review.COVID-19 初始 RT-PCR 检测的假阴性结果:系统评价。
PLoS One. 2020 Dec 10;15(12):e0242958. doi: 10.1371/journal.pone.0242958. eCollection 2020.
7
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.全球 COVID-19 荟萃分析显示,男性性别是死亡和 ICU 入院的风险因素。
Nat Commun. 2020 Dec 9;11(1):6317. doi: 10.1038/s41467-020-19741-6.
8
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age.加拿大 COVID-19 的发病率、临床特征和结局:性别和年龄的影响。
J Ovarian Res. 2020 Nov 24;13(1):137. doi: 10.1186/s13048-020-00734-4.
9
COVID-19 mortality risk for older men and women.COVID-19 对老年男性和女性的死亡率风险。
BMC Public Health. 2020 Nov 19;20(1):1742. doi: 10.1186/s12889-020-09826-8.
10
Trends in COVID-19 Risk-Adjusted Mortality Rates.COVID-19 风险调整死亡率趋势。
J Hosp Med. 2021 Feb;16(2):90-92. doi: 10.12788/jhm.3552.

评估年龄和聚合酶链反应检测结果与 COVID-19 死亡率的性别差异:一项伊朗多中心研究。

Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study.

机构信息

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Expert Rev Anti Infect Ther. 2022 Apr;20(4):631-641. doi: 10.1080/14787210.2022.2000860. Epub 2021 Nov 26.

DOI:10.1080/14787210.2022.2000860
PMID:34753363
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8631692/
Abstract

BACKGROUND

The aim of this study is to evaluate the sex differential effect in the COVID-19 mortality by different age groups and polymerase chain reaction (PCR) test results.

RESEARCH DESIGN

In a multicenter cross-sectional study from 55 hospitals in Tehran, Iran, patients were categorized as positive, negative, and suspected cases.

RESULTS

A total of 25,481 cases (14,791 males) were included in the study with a mortality rate of 12.0%. The mortality rates in positive, negative, and suspected cases were 20.55%, 9.97%, and 7.31%, respectively. Using a Cox regression model, sex had a significant effect on the hazard of death due to COVID-19 in adult and senior male patients having positive and suspected PCR test results. However, sex was not found as significant factor for mortality in patients with a negative PCR test in different age groups.

CONCLUSIONS

Regardless of other risk factors, we found that the effect of sex on COVID-19 mortality varied significantly in different age groups. Therefore, appropriate strategies should be designed to protect adult and senior males from this deadly infectious disease. Furthermore, owing to the considerable death rate of COVID-19 patients with negative test results, new policies should be launched to increase the accuracy of diagnosis tests.

摘要

背景

本研究旨在评估不同年龄组和聚合酶链反应(PCR)检测结果的 COVID-19 死亡率中的性别差异效应。

研究设计

在伊朗德黑兰 55 家医院进行的一项多中心横断面研究中,将患者分为阳性、阴性和疑似病例。

结果

共纳入 25481 例患者(男性 14791 例),死亡率为 12.0%。阳性、阴性和疑似病例的死亡率分别为 20.55%、9.97%和 7.31%。使用 Cox 回归模型,在阳性和疑似 PCR 检测结果的成年和老年男性患者中,性别对 COVID-19 死亡的危害有显著影响。然而,在不同年龄组的 PCR 检测结果为阴性的患者中,性别并不是死亡的显著因素。

结论

无论其他危险因素如何,我们发现性别对 COVID-19 死亡率的影响在不同年龄组中存在显著差异。因此,应制定适当的策略来保护成年和老年男性免受这种致命传染病的侵害。此外,由于 COVID-19 阴性检测结果患者的死亡率相当高,应推出新政策以提高诊断检测的准确性。